Psychiatry

First generic olanzapine to treat schizophrenia, bipolar disorder

The U.S. Food and Drug Administration approved the first generic versions of olanzapine to treat schizophrenia and bipolar disorder. Generic drugs approved by FDA have the same high quality, strength, purity, and stability as brand-name drugs. The generic manufacturing, packaging, and testing sites must pass the same quality standards as those of brand name drugs.
Read more

 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/uc...

Food and Drug Administration